4//SEC Filing
Kilroy Conor 4
Accession 0000950170-24-041803
CIK 0001501796other
Filed
Apr 3, 8:00 PM ET
Accepted
Apr 4, 4:10 PM ET
Size
7.2 KB
Accession
0000950170-24-041803
Insider Transaction Report
Form 4
Kilroy Conor
See Remarks
Transactions
- Award
Common Stock
2024-04-02+96,000→ 96,000 total - Award
Stock Option (Right to Buy)
2024-04-02+144,000→ 144,000 totalExercise: $7.40Exp: 2034-04-01→ Common Stock (144,000 underlying)
Footnotes (2)
- [F1]These shares were acquired pursuant to a restricted stock unit ("RSU") award under the Issuer's 2021 Stock Option and Incentive Plan. Each RSU represents the right to receive one share of the Issuer's Common Stock. These RSUs vest in four substantially equal annual installments beginning on April 15, 2025, subject to the Reporting Person's continued service as of each such vesting date.
- [F2]The shares underlying this option vest as follows: 25% of the shares vest on April 1, 2025 with the remainder vesting thereafter pro-rata in 36 monthly installments, subject to the Reporting Person's continued service as of each such vesting date.
Documents
Issuer
Aura Biosciences, Inc.
CIK 0001501796
Entity typeother
Related Parties
1- filerCIK 0001808510
Filing Metadata
- Form type
- 4
- Filed
- Apr 3, 8:00 PM ET
- Accepted
- Apr 4, 4:10 PM ET
- Size
- 7.2 KB